The Interplay between Fe
Adenocarcinoma
/ drug therapy
Antineoplastic Agents
/ chemistry
Butyric Acid
/ chemistry
Cell Line
Cell Line, Tumor
Cell Survival
/ drug effects
Colonic Neoplasms
/ drug therapy
Drug Delivery Systems
/ methods
Ferric Compounds
/ chemistry
Folate Receptors, GPI-Anchored
/ metabolism
Folic Acid
/ chemistry
Humans
Magnetics
/ methods
Magnetite Nanoparticles
/ chemistry
Polyethylene Glycols
/ chemistry
cellular uptake
folate receptors
magnetic nanoparticles
sodium butyrate
surface functionalization
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Nov 2020
11 Nov 2020
Historique:
received:
23
10
2020
revised:
04
11
2020
accepted:
08
11
2020
entrez:
14
11
2020
pubmed:
15
11
2020
medline:
4
3
2021
Statut:
epublish
Résumé
Combined treatments which use nanoparticles and drugs could be a synergistic strategy for the treatment of a variety of cancers to overcome drug resistance, low efficacy, and high-dose-induced systemic toxicity. In this study, the effects on human colon adenocarcinoma cells of surface modified Fe
Identifiants
pubmed: 33187164
pii: ijms21228473
doi: 10.3390/ijms21228473
pmc: PMC7697628
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Ferric Compounds
0
Folate Receptors, GPI-Anchored
0
Magnetite Nanoparticles
0
Butyric Acid
107-92-6
ferric oxide
1K09F3G675
Polyethylene Glycols
3WJQ0SDW1A
Folic Acid
935E97BOY8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Acc Chem Res. 2015 May 19;48(5):1276-85
pubmed: 25922976
Oncotarget. 2016 Aug 9;7(32):52553-52574
pubmed: 27248175
Cancer Discov. 2014 Dec;4(12):1387-97
pubmed: 25266735
J Pharm Sci. 2000 Nov;89(11):1452-64
pubmed: 11015690
J Mater Chem B. 2015 May 28;3(20):4134-4145
pubmed: 32262291
Sci Rep. 2012;2:980
pubmed: 23243496
Angew Chem Int Ed Engl. 2013 Dec 23;52(52):14152-6
pubmed: 24255024
Int J Mol Sci. 2018 Oct 20;19(10):
pubmed: 30347840
Clin Cancer Res. 2014 Feb 15;20(4):799-803
pubmed: 24270685
Biomaterials. 2008 Aug;29(22):3161-74
pubmed: 18455232
Cancer Metastasis Rev. 2015 Mar;34(1):41-52
pubmed: 25564455
Molecules. 2020 Oct 06;25(19):
pubmed: 33036240
J Colloid Interface Sci. 2004 Mar 15;271(2):277-83
pubmed: 14972603
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1111-1121
pubmed: 28933183
Nanomedicine (Lond). 2011 Oct;6(8):1429-46
pubmed: 22026380
Nat Rev Cancer. 2003 Aug;3(8):601-14
pubmed: 12894248
Acc Chem Res. 2011 Oct 18;44(10):842-52
pubmed: 21661727
Cancer Metastasis Rev. 2015 Sep;34(3):465-78
pubmed: 26224132
Ann Oncol. 2009 May;20 Suppl 4:61-3
pubmed: 19454465
ACS Nano. 2014 May 27;8(5):4705-19
pubmed: 24689973
Cancer Lett. 2013 Aug 9;336(1):8-17
pubmed: 23664890
Curr Opin Chem Biol. 2009 Jun;13(3):256-62
pubmed: 19419901
Nanoscale. 2013 Dec 7;5(23):11438-46
pubmed: 24056724
Chem Soc Rev. 2012 Apr 7;41(7):2912-42
pubmed: 22318454
ACS Nano. 2011 Sep 27;5(9):7124-9
pubmed: 21838221
Mol Cell. 2012 Nov 30;48(4):612-26
pubmed: 23063526
J Pharm Pharm Sci. 2014;17(2):231-47
pubmed: 24934552
J Biol Chem. 1994 Feb 4;269(5):3198-204
pubmed: 8106354
Nephrol Dial Transplant. 2011 Sep;26(9):2948-54
pubmed: 21310738
Clin Transl Immunology. 2016 Apr 22;5(4):e73
pubmed: 27195116
Chem Rev. 2012 Nov 14;112(11):5818-78
pubmed: 23043508
Nanoscale Res Lett. 2018 Feb 07;13(1):45
pubmed: 29417388
Angew Chem Int Ed Engl. 2013 Dec 2;52(49):13047-51
pubmed: 24281889
Biomaterials. 2010 Mar;31(8):2130-40
pubmed: 19995668
Trends Mol Med. 2015 Apr;21(4):223-32
pubmed: 25656384
J Mater Chem B. 2013 Oct 21;1(39):5317-5328
pubmed: 32263334
Cell Biol Toxicol. 2020 Oct;36(5):509-515
pubmed: 32172331